Literature DB >> 11104773

The role of dibasic residues in prohormone sorting to the regulated secretory pathway. A study with proneurotensin.

S Feliciangeli1, P Kitabgi, J N Bidard.   

Abstract

The mechanisms by which prohormone precursors are sorted to the regulated secretory pathway in neuroendocrine cells remain poorly understood. Here, we investigated the presence of sorting signal(s) in proneurotensin/neuromedin N. The precursor sequence starts with a long N-terminal domain followed by a Lys-Arg-(neuromedin N)-Lys-Arg-(neurotensin)-Lys-Arg- sequence and a short C-terminal tail. An additional Arg-Arg dibasic is contained within the neurotensin sequence. Mutated precursors were expressed in endocrine insulinoma cells and analyzed for their regulated secretion. Deletion mutants revealed that the N-terminal domain and the Lys-Arg-(C-terminal tail) sequence were not critical for precursor sorting to secretory granules. In contrast, the Lys-Arg-(neuromedin N)-Lys-Arg-(neurotensin) sequence contained essential sorting information. Point mutation of all three dibasic sites within this sequence abolished regulated secretion. However, keeping intact any one of the three dibasic sequences was sufficient to maintain regulated secretion. Finally, fusing the dibasic-containing C-terminal domain of the precursor to the C terminus of beta-lactamase, a bacterial enzyme that is constitutively secreted when expressed in neuroendocrine cells, resulted in efficient sorting of the fusion protein to secretory granules in insulinoma cells. We conclude that dibasic motifs within the neuropeptide domain of proneurotensin/neuromedin N constitute a necessary and sufficient signal for sorting proteins to the regulated secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104773     DOI: 10.1074/jbc.M009613200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Mutant proinsulin that cannot be converted is secreted efficiently from primary rat beta-cells via the regulated pathway.

Authors:  Philippe A Halban; Jean-Claude Irminger
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

Review 2.  Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines.

Authors:  Patrick Kitabgi
Journal:  J Mol Med (Berl)       Date:  2006-05-11       Impact factor: 4.599

3.  Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway.

Authors:  Leonardo Guizzetti; Rebecca McGirr; Savita Dhanvantari
Journal:  J Biol Chem       Date:  2014-04-11       Impact factor: 5.157

4.  Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination.

Authors:  Vassilios Beglopoulos; Monique Montag-Sallaz; Astrid Rohlmann; Kerstin Piechotta; Mohiuddin Ahmad; Dirk Montag; Markus Missler
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 5.  Sending proteins to dense core secretory granules: still a lot to sort out.

Authors:  Jimmy D Dikeakos; Timothy L Reudelhuber
Journal:  J Cell Biol       Date:  2007-04-16       Impact factor: 10.539

6.  Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization.

Authors:  Lydia H Bederka; Cyrille J Bonhomme; Emily L Ling; Michael J Buchmeier
Journal:  mBio       Date:  2014-10-28       Impact factor: 7.867

7.  Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.

Authors:  Hugo Gagnon; Sarah Refaie; Sandra Gagnon; Roxane Desjardins; Michel Salzet; Robert Day
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  An amphipathic alpha-helix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathway.

Authors:  Elías H Blanco; Carlos F Lagos; María Estela Andrés; Katia Gysling
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.